Nicholas Hornstein, Assistant Professor at Northwell Health, shared a post on X:
“New episode of The Gut Onc Lab!
Pancreatic cancer is finally entering a true era of targeted therapy (and no, this isn’t just another discussion of RAS, although it does come up).
In this episode we have a special guest, and the queen of pancreatic cancer, Kim Reiss Binder, who join myself, Tim Brown, and Udhayvir Grewal, to discuss why 2026 feels different in PDAC.
- BRCA/PALB2-directed treatment.
- PARP maintenance.
- The next wave of RAS-targeted therapies.
The pipeline is moving quickly, and for the first time in a long time, there is real momentum beyond chemotherapy.
Watch the full episode (with video) on:
Spotify.”
Other articles featuring Nicholas Hornstein on OncoDaily.